UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Numerical Solution of the Multiterm Time-Fractional Model for Heat Conductivity by Local Meshless Technique

Complexity (New York, N.Y.), 2021, Vol.2021 (1)

2021

Volltextzugriff (PDF)

Tumor Therapy with Targeted Atomic Nanogenerators

Science (American Association for the Advancement of Science), 2001-11, Vol.294 (5546), p.1537-1540

2001

Volltextzugriff (PDF)

Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature

Cancer research (Chicago, Ill.), 1999-07, Vol.59 (13), p.3192-3198

1999

Volltextzugriff (PDF)

Renal-Cell Carcinoma

The New England journal of medicine, 1996-09, Vol.335 (12), p.865-875

1996

Volltextzugriff (PDF)

Lower and Upper Bounds of Fractional Metric Dimension of Connected Networks

Fractal and fractional, 2021-12, Vol.5 (4), p.276

2021

Volltextzugriff (PDF)

Knowledge, Attitudes, and Practices Toward COVID-19 in a Saudi Arabian Population: A Cross-Sectional Study

Curēus (Palo Alto, CA), 2020-06

2020

Volltextzugriff (PDF)

Prevalence of Delayed Eruption of Permanent Upper Central Incisors at a Tertiary Hospital in Riyadh, Saudi Arabia

Children (Basel), 2022-11, Vol.9 (11), p.1781

2022

Volltextzugriff (PDF)

Constitutive and antibody-induced internalization of prostate-specific membrane antigen

Cancer research (Chicago, Ill.), 1998-09, Vol.58 (18), p.4055-4060

1998

Volltextzugriff (PDF)

Targeted systemic therapy of prostate cancer with a monoclonal antibody to prostate-specific membrane antigen

Seminars in oncology, 2003-10, Vol.30 (5), p.667-676

2003

Volltextzugriff (PDF)

Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor vascular endothelium

Cancer research (Chicago, Ill.), 1997-09, Vol.57 (17), p.3629-3634

1997

Volltextzugriff (PDF)

Phase I dose-escalation study of fractionated dose 177Lu-PSMA-617 for progressive metastatic castration resistant prostate cancer (mCRPC)

Annals of oncology, 2018-10, Vol.29, p.viii274-viii274

2018

Volltextzugriff (PDF)

Folate hydrolase‐1 (FOLH1) is a novel target for antibody‐based brachytherapy in Merkel cell carcinoma

Skin health and disease, 2021-03, Vol.1 (1), p.n/a

2021

Volltextzugriff (PDF)

Evaluation of Transport Properties Effect on the Performance of Gas-Condensate Reservoirs Using Compositional Simulation

Journal of energy resources technology, 2017-05, Vol.139 (3)

2017

Volltextzugriff (PDF)

In vitro characterization of radiolabeled monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen

Cancer research (Chicago, Ill.), 2000-09, Vol.60 (18), p.5237-5243

2000

Volltextzugriff (PDF)

Synthesis and in Vitro Testing of J591 Antibody−Dendrimer Conjugates for Targeted Prostate Cancer Therapy

Bioconjugate chemistry, 2004-11, Vol.15 (6), p.1174-1181

2004

Volltextzugriff (PDF)

Na,K-ATPase beta-subunit is required for epithelial polarization, suppression of invasion, and cell motility

Molecular biology of the cell, 2001-02, Vol.12 (2), p.279-295

2001

Volltextzugriff (PDF)

Mutations of the VHL tumour suppressor gene in renal carcinoma

Nature genetics, 1994-05, Vol.7 (1), p.85-90

1994

Volltextzugriff (PDF)

Mouse-human chimeric anti-epidermal growth factor receptor antibody C225 inhibits the growth of human renal cell carcinoma xenografts in nude mice

Clinical cancer research, 1998-12, Vol.4 (12), p.2957-2966

1998

Volltextzugriff (PDF)

Antigens recognized by autologous antibody in patients with renal‐cell carcinoma

International journal of cancer, 1999-11, Vol.83 (4), p.456-464

1999

Volltextzugriff (PDF)

Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinoma

Clinical cancer research, 1998-11, Vol.4 (11), p.2729-2739

1998

Volltextzugriff (PDF)

Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostate-specific antibody

Lab on a chip, 2010-01, Vol.10 (1), p.27-29

2010

Volltextzugriff (PDF)

An α-particle emitting antibody ([213Bi]J591) for radioimmunotherapy of prostate cancer

Cancer research (Chicago, Ill.), 2000-11, Vol.60 (21), p.6095-6100

2000

Volltextzugriff (PDF)

A Multicenter Trial Evaluation of the Fibrin/Fibrinogen Degradation Products Test for Detection and Monitoring of Bladder Cancer

The Journal of urology, 1997-09, Vol.158 (3), p.801-805

1997

Volltextzugriff (PDF)

Downregulation of Bcl-2 sensitises interferon-resistant renal cancer cells to Fas

British journal of cancer, 2004-07, Vol.91 (1), p.164-170

2004

Volltextzugriff (PDF)

Expression of the tumor-associated gene MN : A potential biomarker for human renal cell carcinoma

Cancer research (Chicago, Ill.), 1997-06, Vol.57 (12), p.2362-2365

1997

Volltextzugriff (PDF)

1 – 25 von 242

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(217)
Mit Volltextzugriff
(184)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(143)
Life Sciences & Biomedicine
(123)
Humans
(122)
Biological And Medical Sciences
(74)
Medical Sciences
(66)
Male
(62)
Animals
(40)
Oncology
(40)
Female
(33)
Nephrology. Urinary Tract Diseases
(30)
Urology & Nephrology
(30)
Tumors Of The Urinary System
(26)
Tumor Cells, Cultured
(25)
Middle Aged
(24)
Mice
(23)
Aged
(21)
Antibodies, Monoclonal
(20)
Adult
(19)
Antibodies, Monoclonal - Therapeutic Use
(19)
Kidneys
(19)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Numerical Solution of the Multiterm Time-Fractional Model for Heat Conductivity by Local Meshless Technique

Tumor Therapy with Targeted Atomic Nanogenerators

Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature

Renal-Cell Carcinoma

Lower and Upper Bounds of Fractional Metric Dimension of Connected Networks

Knowledge, Attitudes, and Practices Toward COVID-19 in a Saudi Arabian Population: A Cross-Sectional Study

Prevalence of Delayed Eruption of Permanent Upper Central Incisors at a Tertiary Hospital in Riyadh, Saudi Arabia

Constitutive and antibody-induced internalization of prostate-specific membrane antigen

Targeted systemic therapy of prostate cancer with a monoclonal antibody to prostate-specific membrane antigen

Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor vascular endothelium

Phase I dose-escalation study of fractionated dose 177Lu-PSMA-617 for progressive metastatic castration resistant prostate cancer (mCRPC)

Folate hydrolase‐1 (FOLH1) is a novel target for antibody‐based brachytherapy in Merkel cell carcinoma

Evaluation of Transport Properties Effect on the Performance of Gas-Condensate Reservoirs Using Compositional Simulation

In vitro characterization of radiolabeled monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen

Synthesis and in Vitro Testing of J591 Antibody−Dendrimer Conjugates for Targeted Prostate Cancer Therapy

Na,K-ATPase beta-subunit is required for epithelial polarization, suppression of invasion, and cell motility

Mutations of the VHL tumour suppressor gene in renal carcinoma

Mouse-human chimeric anti-epidermal growth factor receptor antibody C225 inhibits the growth of human renal cell carcinoma xenografts in nude mice

Antigens recognized by autologous antibody in patients with renal‐cell carcinoma

Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinoma

Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostate-specific antibody

An α-particle emitting antibody ([213Bi]J591) for radioimmunotherapy of prostate cancer

A Multicenter Trial Evaluation of the Fibrin/Fibrinogen Degradation Products Test for Detection and Monitoring of Bladder Cancer

Downregulation of Bcl-2 sensitises interferon-resistant renal cancer cells to Fas

Expression of the tumor-associated gene MN : A potential biomarker for human renal cell carcinoma

Suchergebnisse filtern